# Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

> **NCT00167583** · PHASE3 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 37 (actual)

## Conditions studied

- Behcet's Disease
- Panuveitis
- Posterior Uveitis
- Retinal Vasculitis

## Interventions

- **DRUG:** Cyclosporin A
- **DRUG:** Interferon-alpha2a

## Key facts

- **NCT ID:** NCT00167583
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167583, "Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00167583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*